Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARTEST: ODM-101 vs Stalevo in Parkinson's Disease
NCT01296464Phase 2Completed
- Sponsor
- Orion Corporation
- Start
- Feb 2011
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of ODM-101 in Parkinson's disease (PD), sponsored by Orion Corporation. Started Feb 2011; status: completed.
02
Drugs
ODM-101
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01296464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01296464.